1. Home
  2. INTG vs SCLX Comparison

INTG vs SCLX Comparison

Compare INTG & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intergroup Corporation (The)

INTG

Intergroup Corporation (The)

N/A

Current Price

$37.10

Market Cap

59.3M

Sector

Real Estate

ML Signal

N/A

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$7.76

Market Cap

59.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTG
SCLX
Founded
1965
2011
Country
United States
United States
Employees
N/A
30
Industry
Building operators
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.3M
59.6M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
INTG
SCLX
Price
$37.10
$7.76
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
5.4K
28.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.46
N/A
Revenue
$74,753,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$749.70
P/E Ratio
$84.39
N/A
Revenue Growth
4.43
N/A
52 Week Low
$10.37
$0.18
52 Week High
$42.50
$34.27

Technical Indicators

Market Signals
Indicator
INTG
SCLX
Relative Strength Index (RSI) 63.45 40.52
Support Level $25.16 $7.73
Resistance Level $37.75 $9.00
Average True Range (ATR) 1.71 0.68
MACD 0.45 0.08
Stochastic Oscillator 79.74 6.25

Price Performance

Historical Comparison
INTG
SCLX

About INTG Intergroup Corporation (The)

The Intergroup Corp is a company operating in the real estate sector. It was formed to buy, develop, operate, rehabilitate, and dispose of real property of various types and descriptions, as well as to engage in other related business and investment activities. The company operates through three segments: Hotel, Real Estate, and Investment Transactions. The Hotel Operations segment, which generates the majority of the revenue, covers the operation of the Hilton hotel and garage. The Real Estate Operations segment involves the management of multifamily rental properties, while the Investment Transactions segment includes investments of cash in marketable securities and other assets.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: